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Reversible Myocardial Calcification Following Severe Leptospirosis 
Complicated With Rhabdomyolysis-Induced Acute Kidney 
Injury and Magnesium-Wasting Nephropathy
Raed Zakouta, d, Maria do Carmo Perloirob, Paulo Freitasc
Abstract
We present a patient with leptospirosis infection who presented sep-
tic shock with multiple-organ dysfunction syndrome, severe rhab-
domyolysis and acute myocarditis. He developed biphasic blood 
calcium pattern with hypocalcemia in the oliguric phase followed 
by hypercalcemia during the recovery diuretic phase in the context 
of rhabdomyolysis and oliguric acute kidney injury. Meanwhile, 
he developed an extensive calcification of the myocardium. Severe 
renal magnesium wasting was observed during the convalescence 
phase. Follow-up showed progressive resorption and later almost 
total disappearance of the calcific deposits in the heart by the 18th 
month after discharge. Renal magnesium wasting decreased gradu-
ally, but yet persisted beyond the 18th and was normalized only by 
the 36th month after discharge. We discuss the pathophysiologic 
mechanisms involved in the myocardial calcification and renal 
magnesium wasting and suggest a possibility of a contributing role 
of magnesium renal wasting in mobilization of calcium deposits out 
of myocardium.
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Introduction
Leptospirosis is an important zoonotic emerging disease 
caused by Leptospira interrogans that occurs worldwide. 
Rats are the most common vector for human infection. In-
fected animals shed L. interrogans into their urine. Young 
adult men often become infected, for example, after recre-
ational exposure to infected animal urine-contaminated wa-
ter or soil. Leptospirosis varies from subclinical illness to 
severe potentially fatal disease associated with septic shock 
and multiple organ failure. Severe rhabdomyolysis and po-
tentially fatal acute myocarditis are other important compli-
cations of leptospirosis. Renal involvement is a cardinal fea-
ture of leptospirosis and it ranges from polyuria and solute 
wasting to severe acute kidney injury requiring dialysis. This 
case report describes a patient with severe leptospirosis that 
was complicated with reversible extensive myocardial calci-
fication and hypomagnesemic renal magnesium wasting that 
persisted for several months.
 
Case Report
A previously healthy 40-year-old man was admitted to the 
hospital with a 3-day history of fever, malaise, anorexia, my-
algia, arthralgia, vomiting and diarrhea. He referred recre-
ational activity in his home garden following rainy days 10 
days before the admission. On physical examination he was 
febrile and dehydrated. The rest of physical examination was 
unremarkable. Initial laboratory evaluation revealed hemo-
globin 13.2 g/dL, white blood cell count (WBC) 12.9 × 109/L 
with neutrophils 11.4 × 109/L, platelets 35 × 109/L, PCR 39.2 
mg/dL, AST 41 U/L, ALT 65 U/L, total bilirubin 0.6 mg/dL, 
LDH 157 U/L, CK 332 U/L, sodium 134 mmol/L, potas-
sium 3.9 mmol/L, blood urea nitrogen (BUN) 38 mg/dL and 
creatinine 4.4 mg/dL. Urinalysis was normal. Chest X-ray 
showed bilateral interstitial infiltrates. He initiated intrave-
nous fluid therapy, amoxyciline-clavulanate and clarythro-
mycine after the collection of three blood cultures and one 
urine culture that later yielded negative results. The patient 
rapidly developed septic shock with multiple-organ dysfunc-
tion syndrome including circulatory failure, acute lung in-
jury, hepatic failure, and the acute kidney injury (AKI) had 
progressed to oliguria. He was intubated and transferred to 
the intensive care unit (ICU) on the 2nd hospitalization day. 
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Laboratory evaluation at that point was as follows: WBC 
25.6 × 109/L, neutrophils 21.9 × 109/L, PCR 39.4 mg/dL, 
prothrombin time 19.7 s (INR 1.8), albumin 2.5 mg/dL, 
AST 14,020 U/L, total bilirubin 18 mg/dL, LDH 7,680 U/L, 
CK 100,000 U/L, CK-MB 2,140 U/L, troponine I 123 ng/
mL, sodium 130 mmol/L, potassium 4.8 mmol/L, BUN 
165 mg/dL, creatinine 5.4 mg/dL, magnesium 2.7 mg/dL, 
albumin-corrected calcium 7.8 mg/dL, phosphorus 6.7 mg/
dL. Three sets of two blood cultures were again negative. 
Serologic study for Mycoplasma pneumoniae, Chlamydia 
pneumoniae, Chlamydia psittaci, Legionella pneumophila, 
Borrelia burgdorferi, Rickettsia conorii, Rickettsia rickettsii, 
Rickettsia typhi, cytomegalovirus, Ebstein-Barr virus, hepa-
titis B virus, hepatitis C virus and human immunodeficiency 
virus was negative. Indirect hemagglutination test for lepto-
spirosis (Focus Diagnostics, CA, USA) was also negative. 
Repeated serology for leptospirosis 2 weeks later revealed 
seroconversion with titer 1/800. Electrocardiogram revealed 
sinus rhythm, right bundle-branch block (RBBB) pattern and 
low voltage QRS complexes. In the ICU the patient started 
empiric antibiotic therapy with meropenem and continued 
clarythromicine. Perfusion of dopamine and noradrenaline 
was also started for four and seven days, respectively. He 
was also on continuous veno-venous hemodiafiltration for 
11 days, and thereafter on intermittent hemodialysis (IHD) 
for another 16 days. He was extubated on the 10th day in 
the ICU. After the serologic confirmation of leptospirosis, 
the patient was de-escalated to ceftriaxone and doxycycline. 
During renal replacement therapy and particularly in the 
first few days after the switch to IHD, he had persistent mild 
albumin-corrected hypocalcemia with the need for perfusion 
of calcium gluconate. When IHD was stopped on the 27th 
day in ICU, serum creatinine was 3.4 mg/dL and albumin-
corrected calcium was 10.5 mg/dL. Two days after IHD had 
been stopped; the patient was transferred to medicine ward, 
where he developed progressive polyuria, hypercalcemia 
and hypomagnesemia, with the worst parameters were 6 L/
day, 15.4 mg/dL and 1.4 mg/dL respectively on around the 
10th day after IHD was stopped, with serum creatinine had 
been decreased to 1.2 mg/dL (Fig. 1). Mild hypokalemia and 
metabolic alkalosis were also observed during this diuretic 
phase. The study of parathyroid hormone (PTH)-vitamin D 
axis at that time showed: PTH 3.57 pg/mL (normal range 
12 - 65), 25-hydroxyvitamin D 29 ng/mL (n 12 - 80), and 1, 
25-dihydroxivitamin D (1, 25-(OH)
2
D) < 2.8 pg/mL (n 18 
- 78). At that point, linear calcification on the left border of 
the cardiac silhouette was noticed on chest x-ray (Fig. 2A). 
CT scan showed calcification of left ventricle, parts of right 
ventricle, and interventricular septum (Fig. 2B), and diffuse 
calcification of pelvic and psoas muscles. Kidneys were nor-
mal and with no evidence of nephrolithiasis. Initial trans-
thoracic echocardiogram showed mild left ventricular (LV) 
dilation and impaired global LV systolic function (ejection 
fraction = 45%), with hypokinesia of inferior and posterior 
walls. Trans-mitral flow velocity and mitral annular veloc-
ity made constrictive pericarditis unlikely. Cardiac magnetic 
resonance showed typical pattern of delayed enhancement 
distribution suggestive of myocarditis and virtually excluded 
myocardial infarction. He was medicated with pamidronate 
and fluids. He also had been on intravenous magnesium sul-
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Figure 1. Evolution of serum calcium, phosphorus, magnesium, creatinine and albumin levels during the hospital stay 
and first weeks after discharge.
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phate (6 g/day) and potassium chloride. Furosemide was not 
administered because of the high urinary output. Calcium 
returned toward normal values some days after pamidronate 
administration. Urinary output returned to normal 3 weeks 
after IHD was stopped. After urinary output returned to nor-
mal, serum potassium and acid-base balance normalized, but 
hypomagnesemia persisted. Laboratory evaluation 4 weeks 
after IHD was stopped, while yet on high doses of intrave-
nous magnesium and out of potassium chloride, showed el-
evated urinary magnesium excretion in the presence of hy-
pomagnesemia, suggesting renal wasting of magnesium, and 
also showed severe hypercalciuria despite serum calcium 
had returned to normal (Table 1). He was discharged treated 
with oral magnesium pidolate (4.5 g/day) and angiotensin-
receptor inhibitor. Serial measurements showed gradual de-
crease of magnesiuria and so magnesium supplement was 
tapered. On the 18th month after discharge and while yet 
on oral magnesium pidolate 1.5 g/day; magnesium was 1.7 
mg/dL and FEMg 6.8% (Table 1). On the 36th month after 
discharge, with magnesium supplement had been stopped 
several months earlier; magnesium was 1.9 mg/dL and FEMg 
2.0% (Table 1). Serial echocardiograms after discharge 
showed progressive recovery of global and regional cardiac 
function, maintaining mild LV dilatation (EDd = 60 mm). 
Echocardiogram performed at 36th month after discharge, 
showed normal values of regional strain and strain rate, 
namely in the segments of the inferior and posterior walls. 
Serial CT scans showed progressive resorption and on the 
18th month after discharge, almost total disappearance of 
calcific deposits in the heart (Fig. 2C). CT scan on the 36th 
month after discharge showed only millimetric calcification 
in the left ventricle (Fig. 2D). Electrocardiogram at this time 
showed RBBB, but was otherwise normal.
Discussion
  
Leptospirosis is an emerging infectious disease character-
ized by a broad spectrum of clinical manifestations ranging 
from unapparent infection to fulminant disease associated 
with multiple organ failure. In our patient, the peculiar clini-
cal context of severe sepsis, myocarditis, rhabdomyolysis-
associated acute kidney injury (AKI) and possibly vasopres-
sor therapy promoted calcification of the heart. The patient 
also developed hypomagnesemia due to renal magnesium 
wasting that was yet observed 18 months after the recov-
ery of renal function, in dissimilar from other reported cases, 
where magnesium wasting in leptospirosis was observed in 
the acute phase and completely reversed during the conva-
lescence phase.
Figure 2. A: Chest x-ray: Linear calcification on the left border of the cardiac silhouette. B: CT scan: Calcification 
of left ventricle, parts of right ventricle, and interventricular septum. C: CT scan by the 18th month after discharge: 
Progressive resorption of calcific deposits in the heart. D: CT scan by the 36th month after discharge: Only millimetric 
calcification in the left ventricle.
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Calcification refers to the pathologic deposition of cal-
cium salts in soft tissues. Pathologic calcification can be 
classified as either metastatic, in which calcium deposits in 
normal tissues, or dystrophic, in which calcification occurs 
in previously injured tissues. Metastatic calcification is seen 
in patients on chronic hemodialysis for chronic renal failure, 
whereas causes of dystrophic calcification include, for ex-
ample, myocardial calcification after myocardial infarction 
or myocarditis. In rhabdomyolysis-induced AKI, temporary 
ectopic calcification in affected skeletal muscles is common 
and it can decrease or even disappear within few months [1-
3]. Biphasic calcemic pattern observed here, with hypocalce-
mia in the oliguric phase followed by hypercalcemia during 
the recovery diuretic phase is characteristic for rhabdomyol-
ysis-associated AKI. This sequence reflects widespread de-
position of calcium in damaged muscle and subsequent mo-
bilization of the calcium out from the recovering muscle as 
phosphorous and creatinine values return to normal [1]. The 
combination of increased release of phosphate from injured 
muscle and impaired ability to excrete phosphorous because 
of renal failure causes hyperphosphatemia, the latter causing 
hypocalcemia due to calcium phosphate precipitation. De-
creased production of 1, 25(OH)
2
D by the impaired kidneys 
and resistance of injured muscle to parathyroid hormone are 
believed to be other possible mechanisms of hypocalcemia 
[4]. The fall of phosphate levels after restoration of renal 
function causes release of deposited calcium to the extracel-
lular fluid [4]. Conflicting results implicate the parathyroid 
hormone in these calcemic alterations [5]. However, low 
PTH and 1, 25(OH)
2
D in our patient during the hypercalce-
mic phase could argument that there was no disruption in the 
PTH-vitamin D axis regulating calcium levels, and suggest 
that low PTH was secondary to altered calcium levels [4].
Myocardial calcification has been rarely reported in 
septic shock, despite the high incidence of the later [6-11]. 
Myocardial calcification has been also described in acute 
myocarditis [12, 13]. Those include a case of massive myo-
cardial calcification after acute myocarditis attributed to an 
unidentified infection, complicated with septic shock and 
rhabdomyolysis-induced AKI, where the calcification had 
been gradually diminished in the next 18 months of fol-
low-up [13]. Although elevation of cardiac troponin is well 
documented in sepsis and correlates with the severity of this 
disease, the extremely high levels of cardiac enzymes on 
admission and cardiac MRI suggest myocarditis. It seems 
that the myocardial cells injury and associated oliguric AKI 
Table 1. Laboratory Evaluation Results
1st month 
(after IHD stopped) 18th month 36th month
pH (arterial) 7.439 - 7.425
(HCO3-) (mmol/L) 24.4 - 27.8
pCO2 (mmHg) 36.9 - 43.3
Creatinine (mg/dL) 0.7 1.0 0.9
Sodium (mmol/L) 136 137 137
Potassium (mmol/L) 4.1 4.7 4.5
Calcium (mg/dL) 10.1 9.8 9.6
Magnesium (mg/dL) 1.4 1.7 1.9
U
Na 
(mmol/day)/FE
Na 
(%) - 256/0.9% 191/0.6%
Uk (mmol/day)/FEK (%) - 108/10.8% 60/5.8%
UCa (mg/day) 556 200 165
UMg (mg/day) 501 183 107
FEMg (%) 31% 6.8% 2.0%
PTH (pg/mL) 34.6 - -
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Abbreviations used: UNa, urine sodium; UK, urine potassium; UCa, urine calcium; UMg, urine magnesium; FEMg, fractional 
excretion of magnesium. 
Normal Values: creatinine (0.85 - 1.3 mg/dL), sodium (135 - 148 mmol/L), potassium (3.5 - 5.3 mmol/L), calcium (8.5 
- 10.1 mg/dL), magnesium (1.8 - 2.4 mg/dL), UNa (40 - 220 mmol/day), UK (25 - 125 mmol/day), UCa (42 - 353 mg/day), 
UMg (24 - 225 mg/day), FEMg < 2.2%.
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promoted the precipitation of calcium in the myocardium. 
Although precipitation of calcium in inflamed myocardium 
during the hypercalcemic phase is a tentative explanation, 
there is evidence that calcification might had occurred during 
the hypocalcemia [13, 14]. Moreover, it was also observed in 
patients without a hypercalcemic phase [13]. Disappearance 
of myocardial calcifications in subsequent image studies 
demonstrates that they are temporary and parallel to the ac-
tivity of myocarditis [15]. Although there was improvement 
of cardiac function in subsequent echocardiograms, dilated 
cardiomyopathy as a consequence of severe leptospiral myo-
carditis had occurred.
Calcium administration during the hyperphosphatemic 
period tends to increase extraosseous calcium deposition 
and aggravate tissue damage. To minimize the risk of cal-
cium deposition and delayed hypercalcemia, correction of 
hypocalcemia in rhabdomyolysis-associated AKI should be 
avoided, unless symptomatic or associated with severe hy-
perkalemia. In fact, some authors consider ICU associated 
hypocalcemia as a protective and beneficial response to criti-
cal illness, as it may prevent intracellular hypercalcemia and 
associated tissue damage [16].
Another interesting aspect in this case is the prolonged 
renal magnesium wasting. Tubulointersticial nephritis is the 
cardinal manifestation of AKI in liptospirosis; and is usually 
characterized by polyuria, sodium and potassium renal wast-
ing, and hypokalemia [17]. However, oliguria is described 
in up to 11-24% of patients and it is higher among severe 
forms [18, 19]. Dehydration, rhabdomyolysis and jaundice 
are other involved factors that cause progression to oliguric 
AKI [19, 20]. The pathophysiologic mechanisms of polyuria 
and electrolytes wasting were shown by clinical and experi-
mental studies to be caused by direct leptospiral inhibitory 
action on tubular cells sodium transporters, resulting in more 
distal sodium delivery and subsequent renal potassium loss 
due to its increased secretion in the collecting duct [17, 21-
29]. Sodium-potassium-ATPase (Na-K-ATPase) dysfunc-
tion has been described in the whole nephron or just in the 
proximal tubule [17, 21, 24, 25, 29]. This would be expected 
to reduce the drive through sodium transporters in the api-
cal membrane; the proximal tubule type-3 sodium-hydrogen 
exchanger (NHE3) and the sodium-potassium-chloride co-
transporter (NKCC2) in the thick ascending limb of Henle’s 
loop (TAL). Defective function and decreased expression of 
NHE3 was shown in human and experimental studies [21, 
22, 29, 30]. Impairment of NHE3 function would explain the 
occurrence of proximal renal tubular acidosis in leptospiro-
sis [30]. Detailed in vivo tubular clearance tests were per-
formed in serovar Shermani infected patients and identified 
dysfunction of NKCC2 [27]. In vitro studies demonstrated 
downregulation of NKCC2 activity in the TAL segment by 
serovars Shermani and Copenhageni [22, 28]. However, 
other serovars were shown not to affect or even to up-regu-
late the function of NKCC2, apparently as a compensatory 
response to the greater sodium and water delivery by the 
proximal tubule due to inhibition of NHE3 [21]. Diminished 
expression of aquaporin 1 in the proximal convoluted tubule 
was documented and this might contribute to deficient water 
reabsorption and, therefore, to polyuria [29]. The controver-
sy about the tubular dysfunction might reflect the injury of 
miscellaneous nephron segments, depending on leptospiral 
load, serogroup or examination in different phases of illness 
[27, 31]. Other causes of tubular damage indirectly related 
to leptospira, such as sepsis, tubular ischemia/necrosis, hy-
perbilirubinemia and myoglobinuria might contribute to the 
diversity of tubular defects. Proximal tubular defects other 
than impaired sodium reabsorption have been reported, as 
demonstrated by reports of reversible proximal renal tubular 
acidosis, glycosuria, hyperphosphaturia and hyperuricosuria 
[30, 32, 33]. Incomplete proximal renal tubular acidosis was 
observed in 10% of leptospirosis patients with AKI [26]. 
Cellular transport of most solutes in the proximal tubule 
is coupled to sodium concentration gradient established by 
the activity of basolateral Na-K-ATPase. Therefore, inhibi-
tion of Na-K-ATPase would cause renal solutes loss by the 
apical Na-dependent transporters such as Na-glucose and 
Na-phosphate contransporters. Regardless of the tubule seg-
ment involved, leptospiral inhibition of tubular cells sodium 
transporters is expected to lead to hypermagnesiuria. For 
instance, inhibition of NKCC2 causes reduction of transepi-
thelial voltage and as a result reduces the passive parace-
lullar magnesium reabsorption, leading to renal magnesium 
loss [28]. In fact, hypomagnesemic renal magnesium wast-
ing in leptospirosis has been described in recent literature 
[34-36]. A clinical case report of severe hypomagnesemia 
secondary to renal wasting, requiring large doses of magne-
sium replacement during the acute phase of leptospirosis as-
sociated with non-oliguric AKI was reported [35]. A series 
of 20 patients with leptospirosis reported elevated FEMg in 
15 of them that was more severe and caused hypomagne-
semia in patients who also had hypovolemic shock and oli-
guric AKI on admission [34]. Evidence of proximal tubule 
damage was observed in all these patients, including hyper-
phosphaturia in 50% of them, but these alterations regressed 
to normal within 2 weeks. Urinary calcium excretion and 
the activity of the Na-Cl co-transporter in the distal convo-
luted tubule, a transporter which involvement could lead to 
renal magnesium wasting, were normal in all patients [34]. 
Dysfunction of TAL was suggested to be the likely cause 
of hypermagnesiuria [34]. Due to absence of hypokalemic 
metabolic alkalosis, Khositseth et al suggested that dysfunc-
tion of NKCC2 could not explain renal magnesium wast-
ing in his patients and proposed direct leptospiral damage 
to renal tight junction protein paracellin-1 (claudin 16) as a 
possible mechanism [34]. In TAL, claudins 16 and 19 form 
the pore permitting paracellular magnesium reabsorption, a 
process which depends on the transepithelial voltage which 
is, nevertheless, maintained by the activity of NKCC2. In 
96                                                                                                                                                                                                                                                                                                                                                                                                                                                97
J Med Cases  •  2013;4(2):92-98Zakout et al
Articles © The authors   |   Journal compilation © J Med Cases and Elmer Press™   |   www.journalmc.org
these reports, hypermagnesiuria was transitory during the 
acute phase and regressed or significantly improved in few 
days.
Recovery of glomerular and tubular renal function is 
early and almost complete even in severe forms of lepto-
spirosis [18, 19]. However, a clinical case of a patient with 
dialysis-requiring-AKI who did not recover his renal func-
tion and remained dialysis-dependent was reported [37]. In 
a study by Covic et al, tubular dysfunction persisted after 
a 3-month follow up in 30% of patients with severe lepto-
spirosis who completely recovered their glomerular function 
[26]. In another series of 35 patients by Daher et al, proximal 
sodium reabsorption and FE
Na
 recovered but elevated FE
K
 
and impaired urinary concentration ability yet persisted on 
the 3rd month after discharge; however, by the 6th month 
FE
K
 returned to normal but urinary concentration ability re-
mained altered [19]. In the series by Khositseth et al, hy-
permagnesiuria normalized or significantly improved in few 
days, with FEMg decreasing from values as high as 43.8% 
on admission to 4.5% after 2 weeks [34]. Initially, renal 
magnesium wasting in our patient could be attributed to di-
uretic phase of renal function recovery and to hypercalciuria. 
However, persistence of renal magnesium wasting after the 
patient had both urinary output and renal calcium excretion 
normalized, suggested that it was secondary to leptospiro-
sis-associated tubular dysfunction. Our patient had not been 
treated with diuretics. The absence of metabolic alkalosis or 
hypokalemia, and the normal FEk and FENa in the follow-up 
evaluation realized on the 18th and 36th month made unlike-
ly Bartter’s and Gitelman’s syndromes. Moreover, the serial 
laboratorial evaluation during the extended follow-up period 
showed gradual decrease in the magnitude and later normal-
ization of magnesium renal excretion, proving definitely the 
relationship of hypermagnesiuria to leptospirosis infection, 
and excluding hereditary hypomagnesemic syndromes. Un-
like the previous described reports, renal magnesium wast-
ing and hypomagnesemia in our patient persisted for sev-
eral months and long-term oral magnesium was prescribed 
to maintain normal magnesium. We hypothesize that renal 
magnesium wasting might contributed to the regression of 
the myocardial calcification. It is possible that renal magne-
sium wasting had contributed to increased calcium urinary 
excretion and mobilization of deposited calcium as high uri-
nary magnesium may compete for reabsorption with calcium 
at the TRPV5 channel in the distal convoluted and connect-
ing tubule [38].
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